0001213900-21-003481.txt : 20210121 0001213900-21-003481.hdr.sgml : 20210121 20210121163316 ACCESSION NUMBER: 0001213900-21-003481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210119 FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ganjei James Kelly CENTRAL INDEX KEY: 0001767300 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 21542416 MAIL ADDRESS: STREET 1: 10609 RIVER OAKS LANE CITY: POTOMAC STATE: MD ZIP: 20859 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2021-01-19 0 0001711754 Inmune Bio, Inc. INMB 0001767300 Ganjei James Kelly C/O INMUNE BIO INC., 1200 PROSPECT STREET, SUITE 525 LA JOLLA CA 92037 1 0 0 0 Option (right to buy) 24.82 2021-01-19 4 A 0 15975 0.00 A 2031-01-18 Common Stock 15975 15975 D Each Option represents a right to receive one share of common stock of INmune Bio, Inc. Options granted pursuant to 2019 Stock Incentive Plan. Options shall vest on a pro rata quarterly basis over three years such that all options to purchase the 15,975 shares will have vested on the third anniversary of the grant date. Not applicable /s/ James Kelly Ganjei 2021-01-21